Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Non Opioid Pain Patch Market

ID: MRFR/HC/40521-HCR
100 Pages
Rahul Gotadki
Last Updated: April 24, 2026

Non-Opioid Pain Patch Market Research Report By Application (Chronic Pain Relief, Acute Pain Relief, Postoperative Pain Management, Musculoskeletal Pain Relief), By Material Type (Medicated Patches, Transdermal Patches, Herbal Patches), By Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals, Specialty Clinics), By End Use (Home Care, Hospital Care, Clinical Settings) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Non Opioid Pain Patch Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Application (USD Billion) | |
      1. 4.1.1 Chronic Pain Relief | |
      2. 4.1.2 Acute Pain Relief | |
      3. 4.1.3 Postoperative Pain Management | |
      4. 4.1.4 Musculoskeletal Pain Relief |
    2. 4.2 Healthcare, BY Material Type (USD Billion) | |
      1. 4.2.1 Medicated Patches | |
      2. 4.2.2 Transdermal Patches | |
      3. 4.2.3 Herbal Patches |
    3. 4.3 Healthcare, BY Distribution Channel (USD Billion) | |
      1. 4.3.1 Retail Pharmacy | |
      2. 4.3.2 Online Pharmacy | |
      3. 4.3.3 Hospitals | |
      4. 4.3.4 Specialty Clinics |
    4. 4.4 Healthcare, BY End Use (USD Billion) | |
      1. 4.4.1 Home Care | |
      2. 4.4.2 Hospital Care | |
      3. 4.4.3 Clinical Settings |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Haleon (GB) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Purdue Pharma (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 AcelRx Pharmaceuticals (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Zynerba Pharmaceuticals (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Hikma Pharmaceuticals (GB) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Sorrento Therapeutics (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Galena Biopharma (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Elysium Therapeutics (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY APPLICATION |
    7. 6.4 US MARKET ANALYSIS BY MATERIAL TYPE |
    8. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    9. 6.6 US MARKET ANALYSIS BY END USE |
    10. 6.7 CANADA MARKET ANALYSIS BY APPLICATION |
    11. 6.8 CANADA MARKET ANALYSIS BY MATERIAL TYPE |
    12. 6.9 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    13. 6.10 CANADA MARKET ANALYSIS BY END USE |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION |
    16. 6.13 GERMANY MARKET ANALYSIS BY MATERIAL TYPE |
    17. 6.14 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    18. 6.15 GERMANY MARKET ANALYSIS BY END USE |
    19. 6.16 UK MARKET ANALYSIS BY APPLICATION |
    20. 6.17 UK MARKET ANALYSIS BY MATERIAL TYPE |
    21. 6.18 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    22. 6.19 UK MARKET ANALYSIS BY END USE |
    23. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION |
    24. 6.21 FRANCE MARKET ANALYSIS BY MATERIAL TYPE |
    25. 6.22 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    26. 6.23 FRANCE MARKET ANALYSIS BY END USE |
    27. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION |
    28. 6.25 RUSSIA MARKET ANALYSIS BY MATERIAL TYPE |
    29. 6.26 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    30. 6.27 RUSSIA MARKET ANALYSIS BY END USE |
    31. 6.28 ITALY MARKET ANALYSIS BY APPLICATION |
    32. 6.29 ITALY MARKET ANALYSIS BY MATERIAL TYPE |
    33. 6.30 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    34. 6.31 ITALY MARKET ANALYSIS BY END USE |
    35. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION |
    36. 6.33 SPAIN MARKET ANALYSIS BY MATERIAL TYPE |
    37. 6.34 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    38. 6.35 SPAIN MARKET ANALYSIS BY END USE |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY MATERIAL TYPE |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END USE |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY APPLICATION |
    45. 6.42 CHINA MARKET ANALYSIS BY MATERIAL TYPE |
    46. 6.43 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    47. 6.44 CHINA MARKET ANALYSIS BY END USE |
    48. 6.45 INDIA MARKET ANALYSIS BY APPLICATION |
    49. 6.46 INDIA MARKET ANALYSIS BY MATERIAL TYPE |
    50. 6.47 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    51. 6.48 INDIA MARKET ANALYSIS BY END USE |
    52. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION |
    53. 6.50 JAPAN MARKET ANALYSIS BY MATERIAL TYPE |
    54. 6.51 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    55. 6.52 JAPAN MARKET ANALYSIS BY END USE |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY MATERIAL TYPE |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END USE |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY MATERIAL TYPE |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY END USE |
    64. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION |
    65. 6.62 THAILAND MARKET ANALYSIS BY MATERIAL TYPE |
    66. 6.63 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    67. 6.64 THAILAND MARKET ANALYSIS BY END USE |
    68. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION |
    69. 6.66 INDONESIA MARKET ANALYSIS BY MATERIAL TYPE |
    70. 6.67 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    71. 6.68 INDONESIA MARKET ANALYSIS BY END USE |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY MATERIAL TYPE |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY END USE |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION |
    78. 6.75 BRAZIL MARKET ANALYSIS BY MATERIAL TYPE |
    79. 6.76 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    80. 6.77 BRAZIL MARKET ANALYSIS BY END USE |
    81. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION |
    82. 6.79 MEXICO MARKET ANALYSIS BY MATERIAL TYPE |
    83. 6.80 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    84. 6.81 MEXICO MARKET ANALYSIS BY END USE |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY MATERIAL TYPE |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY END USE |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL TYPE |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL TYPE |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USE |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL TYPE |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USE |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY MATERIAL TYPE |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY END USE |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY MATERIAL TYPE, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY MATERIAL TYPE, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY END USE, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END USE, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END USE, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END USE, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END USE, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END USE, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END USE, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END USE, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END USE, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END USE, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END USE, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END USE, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END USE, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END USE, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END USE, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END USE, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END USE, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END USE, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END USE, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END USE, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END USE, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END USE, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END USE, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END USE, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END USE, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END USE, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END USE, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END USE, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END USE, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY MATERIAL TYPE, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END USE, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

  • Chronic Pain Relief
  • Acute Pain Relief
  • Postoperative Pain Management
  • Musculoskeletal Pain Relief

Healthcare By Material Type (USD Billion, 2025-2035)

  • Medicated Patches
  • Transdermal Patches
  • Herbal Patches

Healthcare By Distribution Channel (USD Billion, 2025-2035)

  • Retail Pharmacy
  • Online Pharmacy
  • Hospitals
  • Specialty Clinics

Healthcare By End Use (USD Billion, 2025-2035)

  • Home Care
  • Hospital Care
  • Clinical Settings

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions